il 2 elisa kit (Sino Biological)
Structured Review

Il 2 Elisa Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kit11848/Human+IL2+ELISA+Kit/pmc12303003-52-0-4
Average 94 stars, based on 9 article reviews
Images
1) Product Images from "Interferon-α and thymosin-α1 plus tislelizumab enhance CD8 + T cell cytotoxicity toward pancreatic ductal adenocarcinoma"
Article Title: Interferon-α and thymosin-α1 plus tislelizumab enhance CD8 + T cell cytotoxicity toward pancreatic ductal adenocarcinoma
Journal: iScience
doi: 10.1016/j.isci.2025.113053
Figure Legend Snippet: Influence of tislelizumab, IFN-α, and Tα1 on the surface PD-1 expression of CD8 + T cells (A) Statistical analysis of the number of CD8 + T cells at different times within 14 days after incubation with 1 μg/mL of tislelizumab with or without IFN-α and Tα1 treatment, as determined by a CCK8 assay. (B–D) Statistical analysis of the levels of the secreted cytokines IL-2 (B), TNF-α (C), and IFN-γ (D) in suspensions of cultured CD8 + T cells after incubation with 1 μg/mL of tislelizumab with or without the addition of IFN-α and Tα1 for 14 days, as assayed by ELISA. The data were analyzed by one-way ANOVA and are presented as the means ± SDs of four or five biological replicates. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.
Techniques Used: Expressing, Incubation, CCK-8 Assay, Cell Culture, Enzyme-linked Immunosorbent Assay
Related Articles
Incubation:Article Title: Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4. Article Snippet: .. After incubation, the culture supernatants were collected and assessed for the secretion of IL-2 using the Enzyme-linked Immunosorbent Assay:Article Title: Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4. Article Snippet: .. After incubation, the culture supernatants were collected and assessed for the secretion of IL-2 using the Article Title: Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors. Article Snippet: Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b), a member of the Cbl family of RING finger E3 ubiquitin ligases, plays a critical role in negatively regulating T-cell, natural killer (NK) cell, and B-cell activation.. Inhibiting Cbl-b has emerged as a promising immuno-oncology strategy to enhance immune cell function.. Here, we describe the rational design and optimization of pyrrolo-pyridone derivatives as potent Cbl-b inhibitors. Cell Culture:Article Title: Rational design, optimization, and biological evaluation of novel pyrrolo-pyridone derivatives as potent and orally active Cbl-b inhibitors. Article Snippet: Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b), a member of the Cbl family of RING finger E3 ubiquitin ligases, plays a critical role in negatively regulating T-cell, natural killer (NK) cell, and B-cell activation.. Inhibiting Cbl-b has emerged as a promising immuno-oncology strategy to enhance immune cell function.. Here, we describe the rational design and optimization of pyrrolo-pyridone derivatives as potent Cbl-b inhibitors. other:Article Title: Interferon-α and thymosin-α1 plus tislelizumab enhance CD8 + T cell cytotoxicity toward pancreatic ductal adenocarcinoma Article Snippet: |